The RCP has responded to the news of the Oxford-AstraZeneca COVID-19 vaccine being approved for use in the UK.
The Oxford-AstraZeneca vaccine has today been approved for use in the UK, marking a momentous occasion in the advancement of medical research.
In response to the news, Professor Andrew Goddard, president of the RCP said:
“The authorisation of the Oxford-AstraZeneca vaccine is brilliant news. The pandemic is bringing the NHS to its knees and this is the way out.
"Frontline NHS and care staff must be vaccinated in the next couple of weeks as a priority as the current pressures on the NHS will be impossible to withstand without a fit and protected workforce."